ArticleDisease models & mechanisms2017
New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes.
Open access · goldAbstract read
In one paragraph
Article in Disease models & mechanisms, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
8.1field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.
- Estimating the effect size of the 15Q11.2 BP1-BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice.Journal of medical genetics · 2019Pooled it
- Translational dysregulation as a mechanistic driver of cognitive, behavioral, and affective phenotypes in FXS and TSC.Neuroscience and biobehavioral reviews · 2026Review
- Article
- Control of microglial dynamics by the Arp2/3 complex and the autism- and schizophrenia-associated protein CYFIP1.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Article
- Disulfidptosis modification patterns are involved in the immune microenvironment regulation of septic acute respiratory distress syndrome.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026Article
- Multi-omics analysis reveals discordant proteome and transcriptome responses in larval guts of Frankliniella occidentalis infected with an orthotospovirus.Insect molecular biology · 2025Article
- Altered development and network connectivity in a human neuronal model of 15q11.2 deletion-related neurodevelopmental disorders.Translational psychiatry · 2025Article
- The WAVE complex in developmental and adulthood brain disorders.Experimental & molecular medicine · 2025Review
- Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions.Biomarker research · 2024Review
- Triple Genetic Diagnosis in a Patient with Late-Onset Leukodystrophy and Mild Intellectual Disability.International journal of molecular sciences · 2023Article
- Orchestration of synaptic functions by WAVE regulatory complex-mediated actin reorganization.Experimental & molecular medicine · 2023Review
- Quantity as a Fish Views It: Behavior and Neurobiology.Frontiers in neuroanatomy · 2022Review
- Identification of GOLPH3 Partners inCells · 2021Article
- Cytoplasmic FMR1 interacting protein (CYFIP) family members and their function in neural development and disorders.Molecular biology reports · 2021Review
- Kaposi's Sarcoma-associated Herpesvirus microRNA mutants modulate cancer hallmark phenotypic differences in human endothelial cells.Journal of virology · 2021Article
- The molecular biology of FMRP: new insights into fragile X syndrome.Nature reviews. Neuroscience · 2021Review
- Agonist-induced functional analysis and cell sorting associated with single-cell transcriptomics characterizes cell subtypes in normal and pathological brain.Genome research · 2020Article
- FMRP and CYFIP1 at the Synapse and Their Role in Psychiatric Vulnerability.Complex psychiatry · 2020Review
- Investigating Developmental and Epileptic Encephalopathy UsingInternational journal of molecular sciences · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors at 8 institutions in 6 countries.
Sabiha AbekhoukhUniversité Côte d'Azur, Nice, France.ORCID 0000-0002-8654-2307
H Bahar SahinInstitut de Génétique et de Biologie Moléculaire et Cellulaire, 67400 Illkirch, France.ORCID 0000-0002-5221-7637
Mauro GrossiUniversité Côte d'Azur, Nice, France.ORCID 0000-0002-2359-7925
Samantha ZongaroUniversité Côte d'Azur, Nice, France.
Thomas MaurinUniversité Côte d'Azur, Nice, France.ORCID 0000-0002-8467-3135
Irene MadrigalBiochemistry and Molecular Genetics Department, Hospital Clinic, 08036 Barcelona, Spain.ORCID 0000-0003-1857-4902
Daniele Kazue-SugiokaUniversité Côte d'Azur, Nice, France.
Annick Raas-RothschildInstitute of Rare Diseases, Institute of Medical Genetics, The Chaim Sheba Medical Center, Tel Hashomer 52621, Israel.
Mohamed DoulazmiSorbonne Universités, Université Pierre et Marie Curie, Univ Paris 06, CNRS UMR8256, IBPS, Neuroscience Paris Seine, France.
Pilar CarreraInstitut de Génétique et de Biologie Moléculaire et Cellulaire, 67400 Illkirch, France.ORCID 0000-0002-3940-9028
Andrea StachonInstituto de Pesquisa Pelé Pequeno Principe, Curitiba 80250-060, Brazil.
Steven SchererHospital for Sick Children, Toronto, Ontario, Canada, M5G 1X8.
Maria Rita Drula Do NascimentoInstituto de Pesquisa Pelé Pequeno Principe, Curitiba 80250-060, Brazil.
Alain TrembleauSorbonne Universités, Université Pierre et Marie Curie, Univ Paris 06, CNRS UMR8256, IBPS, Neuroscience Paris Seine, France.
Ignacio ArroyoCenter for Biomedical Research on Rare Diseases (CIBERER), Barcelona, Spain.
Peter SzatmariCentre for Addiction and Mental Health, Hospital for Sick Children, Department of Psychiatry, University of Toronto, Canada, M5G 1X8.
Isabel M SmithDepartments of Pediatrics and Psychology & Neuroscience, Dalhousie University and IWK Health Centre, Halifax, Canada, B3K 6R8.ORCID 0000-0001-5525-2123
Montserrat MilàBiochemistry and Molecular Genetics Department, Hospital Clinic, 08036 Barcelona, Spain.
Adam C SmithInstituto de Pesquisa Pelé Pequeno Principe, Curitiba 80250-060, Brazil.
Angela GiangrandeInstitut de Génétique et de Biologie Moléculaire et Cellulaire, 67400 Illkirch, France.
Isabelle CailléSorbonne Universités, Université Pierre et Marie Curie, Univ Paris 06, CNRS UMR8256, IBPS, Neuroscience Paris Seine, France.
Barbara BardoniUniversité Côte d'Azur, Nice, France bardoni@ipmc.cnrs.fr.ORCID 0000-0001-6411-1517
Centre National de la Recherche Scientifique · FRCentre for Biomedical Network Research on Rare Diseases · ESInserm · FRCentre for Addiction and Mental Health · CAInstituto de Tecnologia do Paraná · BRDalhousie University · CAHospital for Sick Children · CASheba Medical Center · IL
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cytoplasmic FMRP interacting protein 1 (
Indexed as
Adaptor Proteins, Signal TransducingAnimalsCells, CulturedDrosophila melanogasterDrosophila ProteinsEpistasis, GeneticFragile X Messenger Ribonucleoprotein 1Gene Knockout TechniquesGene SilencingHumansMice, Inbred C57BLMultiprotein ComplexesNerve Tissue ProteinsNeuronsOlfactory BulbRNA, MessengerAdaptor Proteins, Signal TransducingCyfip1 protein, mouseDrosophila ProteinsFragile X Messenger Ribonucleoprotein 1Multiprotein ComplexesNerve Tissue ProteinsRNA, MessengerSra-1 protein, DrosophilaWiskott-Aldrich Syndrome Protein FamilyAutismBP1-BP2 deletionCYFIP1Fragile XIntellectual disability
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.